NASDAQ · Medical - Devices

BBLG (BBLG) Stock

$1.02 -4.21% NASDAQ: BBLG Healthcare

Valuation

MetricValue
Price$1.02
Market Cap$1.84M
P/E Ratio-1.10
P/B Ratio0.46
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$6.75
52-Week Low$1.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-70.17%
ROA-41.87%
ROCE-50.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-4.0M$-9.0M$-4.0M$-3.0M
Net Profit$-2.0M$-1.0M$-9.0M$-4.0M$-3.0M
EPS$-37.35$-31.20$-34.01$-4.83$-2.65
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$7.0M$8.0M$4.0M$4.0M$6.0M
Total Liabilities$0$3.0M$1.0M$0$0
Cash$7.0M$8.0M$3.0M$3.0M$5.0M
Borrowings$0$0$0$0$0

Latest News

BBLG Secures Financing for Critical Trials Zacks Small Cap Research · Jul 8, 2026 Bone Biologics Prices Up to $9 Million Private Placement of Stock, Warrants MT Newswires · Jul 8, 2026 Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules GlobeNewswire · Jul 8, 2026 Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 GlobeNewswire · May 19, 2026 BBLG In Good Shape as Critical Tests Underway Zacks Small Cap Research · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-4.0M$-10.0M$-4.0M$-3.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$5.0M$0
Net Cash Flow$7.0M$1.0M$-5.0M$0$2.0M
Free Cash Flow$-1.0M$-4.0M$-10.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-4.50
EV / EBITDA—
FCF Yield-102.23%
Quick Ratio16.09
Interest Coverage—
Return 1Y-57.24%
Return 3Y-98.11%
Return 5Y—

Ownership

Insiders Held0.04%
Institutions Held0.25%
Institutions Float Held0.25%
Institutional HolderSharesReport Date
Tower Research Capital LLC (TRC)4,1262026-03-31
SBI Securities Co., Ltd.2302026-03-31
UBS Group AG562026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BBLG

BBLG is led by CEO Jeffrey Frelick, employs 2 people, headquartered in US, publicly traded since 2021.

BBLG stock trades at $1.02 with a market capitalization of $1.84M. The stock is valued at a price-to-earnings (P/E) ratio of -1.10, price-to-book of 0.46, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.02 and $6.75, and currently trades 84.9% below its 52-week high.

On profitability, BBLG generates a return on equity (ROE) of -70.17%, return on capital employed of -50.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides